Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Forodesine hydrochloride

EU orphan designation number: EU/3/06/421   
Active ingredient: Forodesine hydrochloride
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: Napp Pharmaceuticals Research Limited
Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0WG, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/12/2006 Centralised Orphan - Designation EMEA/OD/070/06 (2006)7016 of 18/12/2006
07/08/2007 Other procedure